- Home
- AGRO vs ESPR Comparison
AGRO vs ESPR Comparison
Compare AGRO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGRO
- ESPR
- Stock Information
- Founded
- AGRO 2002
- ESPR 2008
- Country
- AGRO Luxembourg
- ESPR United States
- Employees
- AGRO N/A
- ESPR N/A
- Industry
- AGRO Farming/Seeds/Milling
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- AGRO Consumer Staples
- ESPR Health Care
- Exchange
- AGRO Nasdaq
- ESPR Nasdaq
- Market Cap
- AGRO 790.5M
- ESPR 660.1M
- IPO Year
- AGRO 2011
- ESPR 2013
- Fundamental
- Price
- AGRO $7.87
- ESPR $3.68
- Analyst Decision
- AGRO Sell
- ESPR Buy
- Analyst Count
- AGRO 2
- ESPR 7
- Target Price
- AGRO $9.00
- ESPR $6.86
- AVG Volume (30 Days)
- AGRO 411.2K
- ESPR 7.0M
- Earning Date
- AGRO 11-11-2025
- ESPR 11-06-2025
- Dividend Yield
- AGRO 4.46%
- ESPR N/A
- EPS Growth
- AGRO N/A
- ESPR N/A
- EPS
- AGRO 0.23
- ESPR N/A
- Revenue
- AGRO $1,386,018,000.00
- ESPR $303,802,000.00
- Revenue This Year
- AGRO N/A
- ESPR $18.83
- Revenue Next Year
- AGRO $0.66
- ESPR N/A
- P/E Ratio
- AGRO $33.74
- ESPR N/A
- Revenue Growth
- AGRO N/A
- ESPR 2.83
- 52 Week Low
- AGRO $7.42
- ESPR $0.69
- 52 Week High
- AGRO $11.79
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- AGRO 49.05
- ESPR 71.27
- Support Level
- AGRO $7.52
- ESPR $2.66
- Resistance Level
- AGRO $7.99
- ESPR $3.26
- Average True Range (ATR)
- AGRO 0.28
- ESPR 0.23
- MACD
- AGRO -0.01
- ESPR 0.05
- Stochastic Oscillator
- AGRO 38.24
- ESPR 94.43
About AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.